Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AUXL Auxilium Pharmaceuticals (AUXL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get Auxilium Pharmaceuticals alerts: Email Address About Auxilium Pharmaceuticals Stock (NASDAQ:AUXL) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...Click here for the ticker >>> Get AUXL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.32 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAuxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in men’s healthcare. The company’s products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.Read More… Retire off just one stock ticker? (Ad)ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...Click here for the ticker >>> Receive AUXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Auxilium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AUXL Stock News HeadlinesElevated Signals and Auxilium Partner to Recover the $3.4 Trillion of Critical Minerals in Mining WasteApril 17, 2024 | tmcnet.comAUX/ETH - Auxilium EthereumJanuary 1, 2024 | investing.com10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIMES bigger gains than physical gold. That's why I've put together a special presentation on this opportunity...September 28, 2024 | Monument Traders Alliance (Ad)AUX/USD - Auxilium US DollarSeptember 14, 2023 | investing.com'Male menopause is a myth'April 22, 2023 | dailymail.co.ukMarine Pharmaceuticals Market to grow by USD 1.56 Bn; Oncology to be the largest revenue generating segment - TechnavioNovember 19, 2022 | finance.yahoo.comWhy Auxilium Pharmaceutical (AUXL) Stock Is Down This MorningSeptember 13, 2022 | thestreet.comAuxilium Pharmaceuticals' Slow Response to Endo Troubles InvestorsAugust 27, 2022 | thestreet.comSee More Headlines AUXL Stock Analysis - Frequently Asked Questions How were Auxilium Pharmaceuticals' earnings last quarter? Auxilium Pharmaceuticals Inc (NASDAQ:AUXL) issued its quarterly earnings results on Thursday, October, 30th. The biopharmaceutical company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.30. Auxilium Pharmaceuticals's revenue for the quarter was up 1.4% on a year-over-year basis. What other stocks do shareholders of Auxilium Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Auxilium Pharmaceuticals investors own include Royalty Pharma (RPRX), Yelp (YELP), AEGR (AEGR), Arctos NorthStar Acquisition (ANAC), MannKind (MNKD), Netflix (NFLX) and Acorda Therapeutics (ACOR). Company Calendar Last Earnings10/30/2014Today9/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:AUXL CUSIP05334D10 CIK1182129 Webwww.auxilium.com Phone+1-484-3215900FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:AUXL) was last updated on 9/28/2024 by MarketBeat.com Staff From Our PartnersThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | Sponsored50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly ...Chaikin Analytics | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Auxilium Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Auxilium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.